We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Bristol-Myers Squibb Pharmaceutical Limited

Watery Lane, Swords, Co. Dublin,
Telephone: 1 800 749 749
Medical Information Direct Line: Freephone: 1 800 749 749
Medical Information e-mail: Medical.information@bms.com
Patient Information Leaflet last updated on medicines.ie: 21/04/2017
PIL OPDIVO 10 mg/mL concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 21/04/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 31/03/2017 and displayed until 21/04/2017
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 01/03/2017 and displayed until 31/03/2017
Reasons for adding or updating:
  • Change to section 6 - date of revision
Updated on 03/02/2017 and displayed until 01/03/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Company name change or merger
Updated on 06/01/2017 and displayed until 03/02/2017
Reasons for adding or updating:
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
Updated on 01/12/2016 and displayed until 06/01/2017
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 12/05/2016 and displayed until 01/12/2016
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to side-effects
  • Change to date of revision
Updated on 07/04/2016 and displayed until 12/05/2016
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 21/12/2015 and displayed until 07/04/2016
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 03/11/2015 and displayed until 21/12/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 23/06/2015 and displayed until 03/11/2015
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Nivolumab